H.Res. 803: Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
Latest action, October 10, 2025: Submitted in House
Latest action, October 10, 2025: Submitted in House